Plant ID: NPO4446
Plant Latin Name: Prunus davidiana
Taxonomy Genus: Prunus
Taxonomy Family: Rosaceae
NCBI TaxonomyDB:
151430
Plant-of-the-World-Online:
729634-1
Analgesic; Antiasthmatic; Anticoagulant; Antitussive; Aperient; Emollient; Haemolytic
South Korea; China; South Africa
FFAR1; FFAR4; | |
TSHR; | |
FAAH; TERT; ALOX15; HPGD; | |
PPARD; PPARA; PPARG; | |
FABP3; LMNA; FABP5; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | FAAH | Anandamide amidohydrolase | O00519 | CHEMBL2243 |
Enzyme_unclassified | TERT | Telomerase reverse transcriptase | O14746 | CHEMBL2916 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARG | Peroxisome proliferator-activated receptor gamma | P37231 | CHEMBL235 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 9.232E-08 | 2.234E-04 | FABP3, PPARA, PPARD, PPARG |
BP | GO:0050896; response to stimulus | GO:0050728; negative regulation of inflammatory response | 8.178E-07 | 1.039E-03 | FFAR4, PPARA, PPARD, PPARG |
BP | GO:0008283; cell proliferation | GO:0048660; regulation of smooth muscle cell proliferation | 1.256E-06 | 1.216E-03 | HPGD, PPARD, PPARG, TERT |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 4.177E-06 | 2.933E-03 | PPARA, PPARG |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 4.310E-06 | 2.933E-03 | PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 6.262E-06 | 3.788E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 6.262E-06 | 3.788E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 6.262E-06 | 3.788E-03 | ALOX15, HPGD |
MF | GO:0005488; binding | GO:0050543; icosatetraenoic acid binding | 6.262E-06 | 3.788E-03 | FABP3, PPARG |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 7.575E-06 | 4.458E-03 | PPARA, PPARD, PPARG |
BP | GO:0050896; response to stimulus | GO:0042060; wound healing | 1.693E-05 | 9.214E-03 | ALOX15, PPARA, PPARD |
BP | GO:0050896; response to stimulus | GO:0070542; response to fatty acid | 1.899E-05 | 9.397E-03 | FABP3, FFAR1, PPARG |
MF | GO:0060089; molecular transducer activity | GO:0004955; prostaglandin receptor activity | 1.876E-05 | 9.397E-03 | HPGD, PPARG |
BP | GO:0008152; metabolic process | GO:1902894; negative regulation of pri-miRNA transcription from RNA polymerase II promoter | 2.292E-05 | 9.570E-03 | PPARA, PPARD |
MF | Unclassified; | GO:0004872; receptor activity | 2.404E-05 | 9.570E-03 | FFAR1, FFAR4, HPGD, PPARA, PPARD, PPARG, TSHR |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 5.312E-10 | 1.647E-08 | FABP3, FABP5, PPARG, PPARA, PPARD |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 7.149E-03 | 7.387E-02 | PPARA, TSHR |
09160 Human Diseases | 09161 Cancers | hsa05202 | Transcriptional misregulation in cancer | 5.886E-03 | 7.387E-02 | HPGD, PPARG |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 2.653E-02 | 1.040E-01 | PPARG, PPARD |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 1.869E-02 | 1.040E-01 | PPARG |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.869E-02 | 1.040E-01 | ALOX15 |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 3.643E-02 | 1.040E-01 | PPARD |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 3.581E-02 | 1.040E-01 | TSHR |
09150 Organismal Systems | 09152 Endocrine system | hsa04922 | Glucagon signaling pathway | 6.372E-02 | 1.040E-01 | PPARA |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04931 | Insulin resistance | 6.860E-02 | 1.040E-01 | PPARA |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | FFAR1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | FFAR1; |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR; |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | FFAR1; |